Have a feature idea you'd love to see implemented?
Let us know!
GDRX GoodRx Holdings Inc
Price (delayed)
$4.9
Market cap
$1.87B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.03
Enterprise value
$1.99B
GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different
Highlights
GoodRx Holdings's net income has surged by 72% QoQ
The debt is down by 23% YoY and by 23% from the previous quarter
The company's EPS has shrunk by 200% YoY but it has surged by 77% QoQ
GoodRx Holdings's equity has decreased by 21% YoY but it has increased by 4% from the previous quarter
The quick ratio has decreased by 38% YoY and by 28% from the previous quarter
Key stats
What are the main financial stats of GDRX
Market
Valuations
Earnings
Shares outstanding
381.14M
Market cap
$1.87B
Enterprise value
$1.99B
Price to book (P/B)
2.67
Price to sales (P/S)
2.35
EV/EBIT
38.39
EV/EBITDA
13.26
EV/Sales
2.52
Revenue
$790.39M
EBIT
$51.8M
EBITDA
$149.91M
Free cash flow
$88.44M
Per share
Balance sheet
Liquidity
EPS
-$0.03
Free cash flow per share
$0.23
Book value per share
$1.84
Revenue per share
$2.08
TBVPS
$2.03
Total assets
$1.35B
Total liabilities
$658.41M
Debt
$544.57M
Equity
$696.43M
Working capital
$512.44M
Debt to equity
0.78
Current ratio
5.48
Quick ratio
4.85
Net debt/EBITDA
0.81
Margins
Efficiency
Dividend
EBITDA margin
19%
Gross margin
93.5%
Net margin
-2.1%
Operating margin
3.7%
Return on assets
-1.1%
Return on equity
-2.4%
Return on invested capital
5.7%
Return on capital employed
4.2%
Return on sales
6.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GDRX stock price
How has the GoodRx Holdings stock price performed over time
Intraday
14.22%
1 week
18.07%
1 month
-25.76%
1 year
-16.1%
YTD
-26.87%
QTD
-29.39%
Financial performance
How have GoodRx Holdings's revenue and profit performed over time
Revenue
$790.39M
Gross profit
$739.19M
Operating income
$29.38M
Net income
-$16.22M
Gross margin
93.5%
Net margin
-2.1%
The operating margin has soared by 197% QoQ
The net margin has soared by 72% from the previous quarter
GoodRx Holdings's net income has surged by 72% QoQ
GDRX's gross profit is up by 11% year-on-year and by 3.1% since the previous quarter
Growth
What is GoodRx Holdings's growth rate over time
Valuation
What is GoodRx Holdings stock price valuation
P/E
N/A
P/B
2.67
P/S
2.35
EV/EBIT
38.39
EV/EBITDA
13.26
EV/Sales
2.52
The company's EPS has shrunk by 200% YoY but it has surged by 77% QoQ
GDRX's P/B is 72% below its 5-year quarterly average of 9.7 and 33% below its last 4 quarters average of 4.0
GoodRx Holdings's equity has decreased by 21% YoY but it has increased by 4% from the previous quarter
The price to sales (P/S) is 78% lower than the 5-year quarterly average of 10.7 and 35% lower than the last 4 quarters average of 3.6
The revenue is up by 7% YoY
Efficiency
How efficient is GoodRx Holdings business performance
The company's return on invested capital has surged by 185% YoY
The company's return on sales has surged by 164% YoY
GoodRx Holdings's ROA has soared by 71% from the previous quarter
The company's return on equity has surged by 70% QoQ
Dividends
What is GDRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GDRX.
Financial health
How did GoodRx Holdings financials performed over time
GoodRx Holdings's total assets is 106% more than its total liabilities
The quick ratio has decreased by 38% YoY and by 28% from the previous quarter
The company's current ratio fell by 33% YoY and by 25% QoQ
The debt is 22% less than the equity
GDRX's debt to equity is down by 26% since the previous quarter and by 3.7% year-on-year
The debt is down by 23% YoY and by 23% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.